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Abstract
Background: Cardiovascular disease is the leading cause of mortality in diabetics, and it has a complex etiology that
operates on several levels. Endothelial dysfunction and increased generation of reactive oxygen species are believed to be
an underlying cause of vascular dysfunction and coronary artery disease in diabetes. This impairment is likely the result of
decreased bioavailability of nitric oxide (NO) within the vasculature. However, it is unclear whether hyperglycemia per se
stimulates NADPH oxidase-derived superoxide generation in vascular tissue.
Methods and Results: This study focused on whether NADPH oxidase-derived superoxide is elevated in vasculature tissue
evoking endothelial/smooth muscle dysfunction in the hyperglycemic (16964 mg%) Goto-Kakizaki (GK) rat. By
dihydroethidine fluorescence staining, we determined that aorta superoxide levels were significantly elevated in 9
month-old GK compared with age matched Wistar (GK; 19566%, Wistar; 10063.5%). Consistent with these findings,
10
26 mol/L acetylcholine-induced relaxation of the carotid artery was significantly reduced in GK rats compared with age
matched Wistar (GK; 4167%, Wistar; 10065%) and measurements in the aorta showed a similar trend (p=.08). In contrast,
relaxation to the NO donor SNAP was unaltered in GK compared to Wistar. Endothelial dysfunction was reversed by
lowering of superoxide with apocynin, a specific Nox inhibitor.
Conclusions: The major findings from this study are that chronic hyperglycemia induces significant vascular dysfunction in
both the aorta and small arteries. Hyperglycemic induced increases in NAD(P)H oxidase activity that did not come from an
increase in the expression of the NAD(P)H oxidase subunits, but more likely as a result of chronic activation via intracellular
signaling pathways.
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Introduction
Of the 24 million diabetic Americans, the vast majority suffer
from noninsulin dependent diabetes mellitus or type 2 diabetes,
while another 57 million Americans are pre-diabetic. Originally
thought to be a metabolic problem, widespread systemic
complications are now recognized. Cardiovascular disease is the
leading cause of mortality in NIDDM has a complex etiology that
operates on several levels to include both atherogenic and
myocardial components [1,2]. The vascular complications include
intermittent claudication, atherosclerosis, hypertension, retinopa-
thy, nephropathy, and congestive heart failure. The vascular
problems of NIDDM individuals are believed to be traceable to
alterations in endothelial function.
Diabetes results in significant impairment of endothelium-
dependent vasodilatation in response to acetylcholine or increases
in flow. This impairment is likely the result of decreased
effectiveness of NO mediated functions within the vasculature. It
is unclear if this impairment is the result of decreased NO synthesis
or bioavailability as a result of an altered vascular phenotype. NO
signaling not only regulates vascular tone, but also inhibits of
components of the atherogenic process including platelet aggre-
gation, monocyte adhesion, and vascular smooth muscle migration
[3,4,5]. Endothelial dysfunction and increased generation of
reactive oxygen species are believed to be an underlying cause
of vascular dysfunction and coronary artery disease in diabetes.
Increased NAD(P)H levels have been observed in the spontaneous
diabetic BB rat also a model of type 1 diabetes [6]. We have
reported in the Zucker fa/fa, a model of type 2 diabetes, an
increase in superoxide generation was observed [7]. All of these
models have both components of hyperlipidemia, hypercholester-
olemia, and hyperglycemia, and it is unclear if hyperglycemia
alone may stimulate NADPH oxidase-derived superoxide gener-
ation in vascular tissue.
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an underlying cause of vascular dysfunction and coronary artery
disease in diabetes. Recent studies have shown that components of
NADPH oxidase are up-regulated in type 1 diabetes in the
vasculature [8]. However, it is unclear whether hyperglycemia per
se stimulates NADPH oxidase-derived superoxide generation in
vascular tissue. The GK rats are a nonobese model of NIDDM
that have elevated fasting glucose, impaired response to glucose,
and increased HbA1c levels at an early age [9,10,11]. Compared
to other diabetic animal models, including the Zucker fa/fa and
Lepr
db mouse, the GK rats are not severely hyperlipidemic or
hypercholesterolemic and present as a model of hyperglycemia
[7,12]. Therefore, the objective of this study was to elucidate
whether endothelial or smooth muscle dysfunction was evident in




Male euglycemic Wistar and diabetic Goto-Kakizaki rats were
used throughout this study (with the exception of Figure 1A) [13].
The GK rats are a nonobese model of NIDDM that have elevated
fasting glucose, impaired response to glucose, and increased
HbA1c levels at an early age [9,10,11]. Experimental protocols
using animals had approval from the New York Medical College
Institutional Animal Care and Use Committee (A3362-01).
Animals were maintained in accordance with institutional polices
and the Public Health Service (NIH:PHS) Policy on Humane Care
and Use of Laboratory Animals (revised 8/2002).
Glucose Tolerance Test (GTT)
Glucose was tested following an overnight fast and started
between 0930 and 1030 the following morning. The animals were
injected with Nembutal (40 mg/kg, i.p.), and then at least
15 minutes allotted to achieve a suitable plane of anesthesia.
Sterile glucose (1.0 g/kg i.p.) was injected into the abdominal
cavity being careful to avoid the g–i tract. Tail vein blood (50 ml)
was sampled at selected intervals (pre-injection, 15, 30, 60,
120 min). HbA1c was determined using the A1CNow kits (Bayer
Healthcare, Tarrytown NY). Blood glucose was determined using
an Accu-Chek monitor (Roche Diagnostics, Indianapolis, IN)
calibrated using known standards. At the end of the protocol, the
animals were given an addition injection of Nembutal (75 mg/kg,
i.p.) prior to tissue harvest.
Vessel isolation and functional studies
The aorta of each animal were carefully exposed and isolated
from the surrounding tissues. The vessels were cleaned from the
adventitia using an operating microscope and microsurgery
instruments. Endothelial function was assessed as previously
described [14,15]. In brief, aortic segments of each animal were
cut into ring segments 1.5 mm in length and mounted on 40 mm
stainless steel wires in the myographs chambers (Danish Myo
Technology A/S, Inc., Denmark) for measurement of isometric
tension. The vessels were superfused with Krebs buffer solution
(118 mmol/L NaCl, 4.7 mmol/L KCl, 1.5 mmol/L CaCl2,
25 mmol/L NaHCO3, 1.1 mmol/L MgSO4, 1.2 mmol/L
KH2PO4, and 5.6 mmol/L glucose; at 37uC; gassed with 95%
air and 5% CO2). After an equilibration period of 1 hour during
which a optimal passive tension was applied to the rings (as
determined from the vascular length-tension relationship), relax-
ations of pre-contracted (by 10
26 mol/L phenylephrine) vessels to
acetylcholine (ACh; from 10
28 to 10
26 mol/L) and the NO donor





NO-mediated microvascular responses were compared by assess-
ing acetylcholine-induced dilation in isolated, pressurized first-order
skeletal muscle arterioles, as we previously reported [16].
Dihydroethidine fluorescence
Production of O2
.2 was determined in segments of the aortas
that were used for functional studies. Hydroethidine, an oxidative
fluorescent dye, was used to localize superoxide production in
situ as we previously reported [17]. In brief, vessels were incubated
with hydroethidine (3610
26 mol/L; at 37uC for 60 min). The
arteries were then washed three times, embedded in OCT
medium and cryosectioned. Fluorescent images were captured
at 610 magnification and analyzed using the Zeiss Axiovision
imaging software. Ten to fifteen entire fields per vessel were
analyzed with one image per field. The mean fluorescence
intensities of ethidium–stained nuclei in the endothelium and
medial layer were calculated for each vessel. Thereafter, these
intensity values for each animal in the group were averaged.
Unstained aortas and vessels pre-incubated with PEG-SOD were
used for background correction and negative control, respectively.
Superoxide Activity
In brief, aortas were homogenized in ice-cold buffer (20 mM
HEPES-pH 7.4, 0.1 mmol/L EDTA, 1 mM glutathione,
10
25 mol/L BH4,1 6proteinase inhibitor. Protein concentration
was determined by the Bradford method. NADPH oxidase
activity, using 5 mM lucigenin, was determined as we have
previously described [18]. NOX-dependent activity was deter-
mined by the addition of (3610
24 mol/L apocynin, 5610
25 mol/
L gp91ss-tat, or 10
26 mol/L diphenyleneiodonium (DPI).
Western Blot Analysis
Tissues were stored at 280uC until used. Aorta samples were
homogenized in ice-cold buffer (20 mmol/L HEPES pH7.5,
50 mmol/L NaCl, 1% SDS, 16 protease inhibitor (Sigma-
Aldrich, P-8340). Protein concentration was determined by the
Bradford method (BioRad reagent). Samples were mixed with
Lamelli buffer, heated to 95uC for 5 min, and loaded onto a SDS-
PAGE and electrophoresis was performed at room temperature.
The gels were blotted onto Hybond-P (Amersham Biosciences,
Piscataway NJ) by a semi-dry transfer protocol. Western analysis
was performed as described previously [19]. Antibodies used
included mouse monoclonal anti-Nox-1, anti-Nox-2, anti-
p67phox, and smooth muscle alpha-actin (Transduction Labora-
tory, San Jose, CA, USA), goat polyclonal anti-Nox-4 and anti-
p47phox (Santa Cruz Biotech, Santa Cruz, CA). Antibody
dilutions were 1:500 for all Nox subunits and 1:2000 for alpha-
actin. Antibody binding was visualized using the Amersham ECL
Plus kit. Band density was quantified using AlphaEaseFC software
(AlphaInnotech, San Leando CA).
RNA Analysis
Total RNA from was isolated using a FASTRNA ProGreen Kit
(Q-Biogene, Irvine CA). Quantification of mRNA levels was done
by QRT-PCR by real-time fluorescent using a Stratagene
MX3000p as described previously [19,20]. The data was
normalized by D2Ct method using b-actin and the fidelity of the
reactions were verified by melting point analysis. Data presented
are the mean6SEM with respect to sedentary control values.
NADPH Oxidase Function in GK
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Statistical analyses were performed using NCSS Software
(NCSS, Kaysville UT). Where appropriate, student t-test or
ANOVA was utilized, post-hoc analysis was done using a Fisher’s
LSD analysis. Values presented are mean6SEM and statistical
significance was set at p,.05.
Results
At 9 months of age the GK weighed significantly less than the
Wistar group (Table 1). When this difference was considered there
was no indication of cardiac hypertrophy, but a significant
increase in the Kidney/BW ratio was observed. Similar to
previous reports the GK rats are both hyperglycemic and have
impaired glucose tolerance (Figure 1).
An impaired vasodilator response has been observed in several
models of diabetes. In the present study we observed that
acetylcholine induced vasorelaxation was impaired in the small
arteries of the diabetic GK (Figure 2A), while, no differences
between control Wistar and diabetic GK were observed in
response to SNAP(a NO donor) (Figure 2B). These results suggest
that diabetes impaired NO bioavailability. One underlying
Figure 1. GK rats are hyperglycemic. A. Fasting blood glucose from GK and Wistar rats at indicated ages. Samples taken in morning after
overnight fast of 16 hours. Values are mean6SEM of 3 to 8 animals. B. GK rats have impaired glucose tolerance. Animals were anesthetized with
Nembutal (40 mg/kg, i.p.). Glucose was injected (1.0 mg/kg i.p.) and blood glucose determined at select intervals. Area under the curve (AUC) analysis
determined that the GK was significantly (p,.05) increased compared to Wistar following injections (Goto-Kakzaki:1263161191 n=8, Wistar:
490261247 n=9 AUC arbitrary units).
doi:10.1371/journal.pone.0011800.g001
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to convert NO to ONOO and H2O. TO determine if superoxide
was increased in the diabetic artery, tissue was stained using DHE.
As shown in Figure 3, we observed significant increases in the
present of superoxide.
Similar to our earlier findings in the myocardium [7], NADPH
directed lucigenin chemiluminescence was significantly increased
in the diabetic aorta compared to the Wistar controls (Figure 4).
No differences in NADH directed lucigenin chemiluminescence
were observed (data not shown). The presence NAD(P)H
inhibitors including pg91
ds-tat, apocynin, and diphenyleneiodo-
nium all reduced chemiluminescence and no differences between
the Wistar and GK groups were observed (Figure 4).
Superoxide may be derived from several sources including
mitochondria, monomeric eNOS, and NAD(P)H oxidase. We have
previously observed that apocynin (an NAD(P)H oxidase inhibitor)
decrease NAD(P)H-directed superoxide generation in the myocardi-
um [21]. To determine the potential role of NAD(P)H derived
superoxide on vascular function, the aorta was preincubated in
apocynin. In response to acetylcholine induced vasorelaxation, no
differences in vasorelaxation between diabetic and control aortas
were observed (Figure 5). This would suggest that NAD(P)H derived
superoxide generation may have been the underlying cause of
vasoactive dysfunction in GK arteries.
NAD(P)H oxidase consisting of 6 subunits and regulation of its
activity is a complex event that we only now just beginning to
understand. One possibility is an increase in the presence of the
responsible components. Etoh et al. reported that the expression of
both Nox4 and p22phox were increased in a STZ-induced model
of diabetes [8]. To that end we have examined expression of
NAD(P)H oxidase components at both the protein and mRNA
levels. We found no significant differences in expression between
the Wistar and GK aortas (Figure 6).
Discussion
The GK rats are a nonobese model of NIDDM that have
elevated fasting glucose, impaired response to glucose, and
increased HbA1c levels at an early age [9,10,11]. Compared to
other animal models of diabetes, the GK rats are not
hyperlipidemic or hypercholesterolemic and present as a model
of hyperglycemia. We have previously determined that GK
hyperglycemia is progressive with age and that exercise training
will significantly lower fasting blood glucose (sedentary; 20569,
exercise trained; 17469 mg%) [20]. Although not hypertensive,
the GK rats exhibit a small but significant increase MAP and
systolic blood pressure compared to their Wistar controls [22]. GK
rats present with many diabetic related complications observed in
human diabetic patients, including reduced nerve conduction
velocity and progressive renal involvement with thickening of the
glomerular basement membranes [10,13,23,24,25,26,27]. It has
been suggested that impaired pancreatic mitochondrial function
may partially explain the depressed insulin release [28,29].
Whether this is related to a shift in mitochondrial antioxidative
capacity resulting in accelerated apoptosis is unclear [30]. Beta-cell
mass and beta-cell replication is decreased in the GK pancreas and
as such the GK rat may represent a model of beta-cell degradation
for human NIDDM [31,32,33]. Genetic linkage analysis of the
Goto-Kakizaki rats has localized different quantitative trait loci to
those involved in diabetes [33,34,35,36,37]. Some regions show
remarkable synteny homology to the diabetic loci found within
human chromosome 1q21–25 [34,35]. More recently Rosengren
et. al. identified a polymorphism in the GK that resulted
overexpression of the a2A-adrenergic receptor leading to
depressed insulin sensitivity [37]. This polymorphism was also
associated with a decreased insulin sensitivity in humans
supporting the concept decreased insulin sensitivity may be one











(g) (g) (g) (%)
Wistar 375619 1.0660.03 1.1460.03 2.5760.05 3.0760.20 4.9060.14
GK 23263 0.8060.02 0.7460.01 3.4160.09 3.1760.04 7.3360.48
p,.05 p,.05 p,.05 p,.05 ns p,.05
doi:10.1371/journal.pone.0011800.t001
Figure 2. Vasorelaxation of small arteries (,150 mm) from 9 month-old GK or Wistar rats is endothelia dependent. A. Diabetes
significantly decreased acetylcholine-induced dilation ($10
26 mol/L) in GK compared to Wistar. B. Diabetes did not alter the response to SNAP (a
nitric oxide donor). Values are mean6SEM of 4 animals. * p,.05 compared to Wistar.
doi:10.1371/journal.pone.0011800.g002
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the human condition.
Diabetes impacts the vasculature on several levels. Increased
generation of reactive oxygen species leading to endothelial
dysfunction is believed to be the major cause of vascular
dysfunction and coronary artery disease in diabetes. The GK rats
represent a model to examine the role of hyperglycemic in
diabetes. The major findings from this study are that chronic
hyperglycemia induces significant vascular dysfunction in both the
aorta and small arteries. Our studies indicate that NAD(P)H
oxidase accounts for a significant portion of intracellular ROS in
the vasculature. Hyperglycemic induced increases in NAD(P)H
oxidase activity did not come from an increase in the expression of
the NAD(P)H oxidase subunits, but more likely as a result of
chronic activation via intracellular signaling pathways.
Endothelium-dependent macrovascular dysfunction has been
observed in several models of diabetes and our results are similar
to others for the larger conduit vessels [22,38,39]. Decreased
endothelial-dependent relaxation of GK aorta and small skeletal
muscle arteries (Figs. 2 & 5), suggest that endothelium-derived NO
is inactivated presumably by hyperglycemia-induced oxidative
stress. Although not hypertensive, the GK rats have a small but
significant increase in MAP and systolic blood pressure compared
to their Wistar controls, and have found to be salt sensitive [22].
Our findings are consistent with an increase in blood pressure as a
function of vascular pathology.
NAD(P)H oxidase, the mitochondrial electron transport chain,
and dysfunctional nitric oxide synthase are the three major sources
of ROS within the cell. Although these sources are thought of as
separate entities, recent papers have suggested significant interac-
Figure 3. DHE fluorescence staining for superoxide. A. 9 month-old Wistar aorta, B. 9 month-old GK aorta. C. Quantification of DHE staining.
Images were collected with a CoolSnap CCD camera attached to an Olympus BX60 microscope. Values are mean6SEM of 4 animals. * p,.05
compared to Wistar.
doi:10.1371/journal.pone.0011800.g003
Figure 4. Diabetes significantly increased superoxide production in aortic tissue. A small portion of the abdominal aorta was resected
from nine month old GK and Wistar rats. Superoxide was determined by lucigenin chemiluminescence, using 5610
26 mol/L lucigenin and
2610
24 mol/L NADPH. To determine if superoxide generation was derived specifically from NADPH tissue samples were incubated with three
different inhibitors of NADPH; apocynin (APO), diphenyleneiodoium (DPI), and gp91ds-tat. Values are mean6SEM of 5 animals. * p,.05 compared to
Wistar control, #p,.05 compared to GK control.
doi:10.1371/journal.pone.0011800.g004
NADPH Oxidase Function in GK
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the conversion of NO to ONOO
2 and uncoupled eNOS and
increased iNOS expression have both been shown to contribute to
oxidant stress in diabetes [40,41,45]. In obese models of NIDDM,
NAD(P)H oxidase derived ROS is increased, and it has been
suggested that elevated vasculature ROS contributes to mitochon-
drial dysfunction in the GK rat [7,46,47]. NOX4 is constitutively
active not requiring activation by p47
phox or p67
phox and its
expression is increased in diabetes and aging [42,44]. Subcellular
localization of NOX4 is cell type dependent with NOX4 being
localized to the mitochondria in cardiomyocytes, in the nucleus of
endothelial cells, and at focal adhesions within vascular smooth
muscle [42,43,44,48,49]. Within vascular smooth muscle, NOX4
is involved in maintenance of the smooth muscle phenotype and
localization to focal adhesions suggests its participation in cell
migration [49,50]. Localization of NOX4 to the endothelial nuclei
could significantly accelerate oxidant stress induce DNA modifi-
cations [49]. In the present study, we find, using an animal model
of chronic hyperglycemia, significant increases ROS generation
via elevated NAD(P)H oxidase activity. The NAP(P)H inhibitors
apocynin as well as gp91
ds-tat, and DPI all reduced superoxide
generation by NAD(P)H oxidase in aortic extracts. Blockage of
NAD(P)H oxidase by apocynin restored endothelial dependent
vasorelaxation. Although our present results clearly demonstrated
NADPH oxidase impacts on endothelial dependent vasculature
function, future work to more clearly examine diabetic induced
changes in NADPH oxidase by cell type and subcellular local are
warranted.
Chronic hyperglycemia did not increased expression of several
components of the NAD(P)H oxidase system and this was observed
at both the protein and mRNA levels These results are similar to
the Zucker fa/fa/rat (type 2) but differ from that observed by
Bitnar et.al who observed increases in p47
phox in younger GK rats
[8,51,52]. Other studies examining T1D models observed
significant increases in NAD(P)H oxidase subunit expression in
the heart and the vasculature suggesting that the pathogenic
mechanisms are not necessarily similar in all models of diabetes
[41,53] In the vasculature, the increase was evident after 4 weeks
but not 16 weeks of diabetes suggesting that altered NAD(P)H
oxidase expression may be a transitional event [53]. The increased
NAD(P)H oxidase activity observed in the present study may have
arisen as a function of chronic activation of the oxidase, either by
increased substrate presentation or increased turnover. Kitahara
et.al reported that G6PD activity is significantly elevated in GK rat
liver and we have observed similar increases in the myocardium
from the Zucker fa/fa rat [51,54]. The primary function of G6PD
is to produce NADPH within the cells and its chronic activation
will elevate NAD(P)H levels. In the Zucker fa/fa rat, chronic
activation of glucose-6-phosphate dehydrogenase (G6PD) was
brought about via a Src kinase [51]. More recently, Liu reported
that high glucose will increased p47phox phosphorylation leading
to activation of NAD(P)H oxidase [55]. Others have reported that
high glucose will enhance p47phox translocation into the
membrane promoting activation of NAD(P)H oxidase [56].
Collectively these reports suggest that NAD(P)H oxidase activity
may be the result of increased activation.
The GK rats are a model of type II diabetes that presents with
hyperglycemia but without severe hyperlipidemia. We have found
that endothelial-dependent dysfunction was observed in both large
and small arteries. Endothelial dysfunction was brought about as a
Figure 5. Apocynin restores vasorelaxation of the diabetic aorta. A. Diabetes significantly decreased acetylcholine-induced dilation $1 mM
in GK compared to Wistar. Apocynin (APO) was used to inhibit NADPH-dependent generation of superoxide. B. Diabetes did not alter the response to
SNAP (a nitric oxide donor). Values are mean6SEM of 5 animals. * p,.05 compared to Wistar.
doi:10.1371/journal.pone.0011800.g005
Figure 6. Diabetes did not significantly alter NOX protein expression. A. Representative western blot, B. Quantification of western blot data
normalized to alpha-actin. No differences were observed between the GK and Wistar groups. C. QRT-PCR of aortic-mRNA. Values are mean6SEM of
4–7 animals. * p,.05 compared to Wistar.
doi:10.1371/journal.pone.0011800.g006
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likely to be the result of chronic activation of NAD(P)H oxidase
activity.
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